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Here we identified Ito cells (hepatic stellate
cells, HSC), known for storage of vitamin A
and participation in hepatic fibrosis, as profes-
sional liver-resident antigen-presenting cells
(APC). Ito cells efficiently presented antigens
to CD1-, major histocompatibility complex
(MHC)-I-, and MHC-II-restricted T cells. Ito cells
presented lipid antigens to CD1-restricted T
lymphocytes such as natural killer T (NKT) cells
and promoted homeostatic proliferation of liver
NKT cells through interleukin-15. Moreover, Ito
cells presented antigenic peptides to CD8+
and CD4+ T cells and mediated crosspriming
of CD8+ T cells. Peptide-specific T cells were
activated by transgenic Ito cells presenting en-
dogenous neoantigen. Upon bacterial infection,
Ito cells elicited antigen-specific T cells and me-
diated protection. In contrast to other liver cell
types that have been implicated in induction of
immunological tolerance, our data identify Ito
cells as professional intrahepatic APCs activat-
ing T cells and eliciting a multitude of T cell re-
sponses specific for protein and lipid antigens.
INTRODUCTION
Ito cells were first described as hepatic stellate cells (HSC)
by the German anatomist Carl von Kupffer in 1876 and
were later defined as fat-storing cells by the Japanese
anatomist Toshio Ito in 1951 (Geerts, 2001). Ito cells are lo-
cated in the liver in the space of Disse, which extends from
endothelial cells lining the sinusoids to the hepatocyte pa-
renchyma, and display an astral phenotype characterized
by several processes (Geerts, 2001). Kupffer cells, which
reflect liver-resident macrophages, and dendritic cells
(DCs) represent different entities from Ito cells and are
mainly located within the sinusoids (Jomantaite et al.,2004). Although the origin of Ito cells is still a matter of vivid
debate (Geerts, 2004), recent work demonstrated their de-
velopment from mesenchymal origin (Baba et al., 2004).
However, Ito cells are defined by expression of ectoder-
mal neural markers such as glial fibrillary acidic protein
(GFAP) (Neubauer et al., 1996). Ito cells account for 8%
of liver cells and store 80% of total body retinol (vitamin
A) as cytoplasmic lipid droplets (Geerts, 2001). In re-
sponse to cellular stress, Ito cells transdifferentiate into
myofibroblasts and produce extracellular matrix including
collagen. Therefore, they have been implicated in the
development of liver fibrosis and subsequent cirrhosis
(Gressner et al., 2002). Moreover, Ito-derived myofibro-
blasts are contractile upon stimulation with vasoactive
substances, suggesting a role in pathogenesis of portal
hypertension (Reynaert et al., 2002).
Natural killer T (NKT) cells represent a distinct subgroup
of T lymphocytes expressing an invariant T cell receptor
(TCR) (Kronenberg, 2005). NKT cells recognize the endog-
enous lipid antigen isoglobotriaosylceramide (iGb3) (Zhou
et al., 2004), multiple exogenous ligands (Mattner et al.,
2005; Kinjo et al., 2005) such as mycobacterial phospha-
tidylinositol-mannoside (PIM) (Fischer et al., 2004), and
a-galactosylceramide (a-GalCer) (Kawano et al., 1997)
presented by CD1d molecules. The family of antigen-
presenting CD1 proteins is related to MHC-I and consists
of group I CD1a-c and group II CD1d on the basis of
sequence homology (Moody and Porcelli, 2003). Whereas
CD1a-c are expressed mainly in humans and present
lipids of microbial origin to T lymphocytes, CD1d exists
in both mice and humans and displays endogenous as
well as bacterial lipids exclusively to NKT cells (Brigl and
Brenner, 2004; Mattner et al., 2005). After lipid antigen
presentation, NKT cells rapidly secrete large amounts of
cytokines such as interferon-g (IFNg) and interleukin-4
(IL-4) to perform immunoregulatory functions (Brigl and
Brenner, 2004). Accordingly, NKT cells exhibit protective
functions in infection (Brigl et al., 2003) and tumor models
(Cui et al., 1997) and are capable of precluding autoim-
mune diseases such as diabetes (Hong et al., 2001) and
multiple sclerosis (Miyamoto et al., 2001).Immunity 26, 117–129, January 2007 ª2007 Elsevier Inc. 117
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(Crispe, 2003), so we searched for the determinants that
render liver tissue such a favorable milieu for NKT cells.
We identified Ito cells to be capable of inducing vigorous
NKT cell responses in vitro and in vivo and promoting ho-
meostatic proliferation of NKT cells through production of
IL-15. Moreover, we found that Ito cells processed protein
antigens and presented peptides to CD4+ and CD8+ T
cells. In an infection model with Listeria monocytogenes,
Ito cells elicited antigen-specific T cells and protected
against infection. Intrinsic production of neoantigen
caused peptide-specific T cell activation by transgenic
Ito cells. Thus, Ito cells are professional APCs in immu-
nology.
RESULTS
Ito Cells Express CD1 Molecules
and APC Surface Markers
In order to investigate the impact of Ito cells on NKT cells,
we isolated Ito cells from liver of C57BL/6mice via the pro-
nase and collagenase perfusion method and subsequent
density gradient centrifugation. In parallel, we performed
experiments in the human system generating Ito cells
from human liver biopsies. Figure 1A shows the star-
shaped phenotype ofmurine and human Ito cells by phase
contrast microscopy. Notably, 3 days after isolation, mu-
rine Ito cells exhibited several processes and lucent cyto-
plasmic vesicles indicating vitamin A-filled lipid droplets
(Figure 1A). To determine purity of Ito cell preparations
and absence of contaminating cells, we stained cell prep-
arations intracellularly for GFAP, a neural marker protein
that is expressed in the liver exclusively by Ito cells (Neu-
bauer et al., 1996). Confocal microscopy revealed the
filamentous distribution of GFAP inmurine aswell as in hu-
man Ito cells (Figure 1B). Surface expression of CD1d on
stimulating cells is a prerequisite for NKT cell activation.
Consequently we performed flow cytometric analysis of
Ito cell-surface proteins. Indeed, Ito cells expressed
CD1d molecules at high cell-surface density (Figure 1C).
Moreover, murine and human Ito cells expressed the anti-
gen-presenting molecule MHC-II and costimulatory mole-
cules such as CD86 (B7-2), which are characteristic
markers for professional APCs (Figure 1C). In contrast,
murine Ito cells failed to express CD11c, which serves
as a DC surface marker underlining the distinct entity of
Ito cells (Figure 1C). Human Ito cells expressed group I
CD1 molecules as indicated by CD1b surface staining
(Figure 1C), thus far exclusively confined to DCs (Brigl
and Brenner, 2004).
Because APCs are able to mature as indicated by upre-
gulation of characteristic surface molcules, we analyzed
Ito cells for their maturation potential. To this end, we stim-
ulated Ito cells with IFNg (500 U/ml) for 3 days and ana-
lyzed surface expression of MHC-I and MHC-II (see
Figure S1 in the Supplemental Data available online). In-
deed, both antigen-presenting molecules were upregu-
lated upon stimulation with IFNg, indicating maturation
ability of Ito cells.118 Immunity 26, 117–129, January 2007 ª2007 Elsevier Inc.To confirm purity of Ito cell preparations, we stained
cells for expression of GFAP and F4/80, a surface protein
expressed by macrophages and Kupffer cells. Flow cyto-
metric analysis revealed high expression of GFAP in
R98.5% of cells in Ito cell preparations (Figure S2A,
left). Cells staining positive for F4/80 were absent in Ito
cell preparations (Figure S2A, right). Combination of pos-
itive staining for GFAP and negative staining for CD11c
and F4/80 excluded contamination of Ito cell preparations
by other liver cell types known to be APCs for activating
T cell responses. In addition, we analyzed Kupffer cell phe-
notype in comparison to Ito cells. Kupffer cells were iden-
tified in fresh liver cell preparations by positive staining for
F4/80 and were analyzed for expression of APC surface
molecules. Kupffer cells highly expressed F4/80 and
MHC-I. Expression of MHC-II, CD1d, and CD86 was de-
tected only at low amounts (Figure S2B). Taken together,
Ito cells display traits of APCs and highly express CD1
molecules.
Ito Cells Induce Vigorous NKT Cell Responses
Since Ito cells expressed CD1d molecules, we examined
the functional impact of Ito cells on NKT cell stimulation.
To this end, we used murine Ito cells or DCs as APCs in
functional T cell assays. After pulsing with the potent
NKT cell antigen a-GalCer, Ito cells or DCs were washed
and cocultured with purified NKT cells isolated from thy-
mus, spleen, or liver of Va14-transgenic animals by nega-
tive selection as described previously (Matsuda et al.,
2002). Ito cells loaded with a-GalCer induced prominent
proliferation of NKT cells from all three organs (Figure 2A).
Addition of CD1d-blocking antibody 1 hr before coculture
with T cells totally abrogated NKT cell activation. More-
over, Ito cells isolated from Cd1d1/ mice failed to stim-
ulate NKT cells after loading with lipid antigen (Figure 2A).
Thus, murine Ito cells potently activated NKT cells in
a CD1d-restricted fashion. In an analogous approach,
we pulsed human Ito cells or DCs with a-GalCer to stimu-
late a human Va24+ NKT cell line. Consistent with the find-
ings in the murine system, lipid antigen-loaded human Ito
cells activated NKT cells (Figure 2B). Blocking CD1d with
a specific antibody abolished NKT cell antigen recognition
(Figure 2B). Incubation of NKT cells alone with a-GalCer
did not induce T cell activation, excluding any impact of
potentially contaminating APCs from primary T cell prep-
arations (data not shown). In addition, we analyzed IFNg
concentrations in cell-culture supernatants from experi-
ments described above with ELISA. Indeed, stimulatory
capacitiy of APCs was reflected by antigen-specific
IFNg secretion of NKT cells (Figures S3A and S3B).
Thus, both human and murine Ito cells are capable of in-
ducing CD1d-restricted NKT cell responses.
Based on these in vitro findings, we questioned whether
Ito cells also function as APCs in vivo. For this purpose, Ito
cells were isolated from wild-type and Cd1d1/ mice,
pulsed with a-GalCer, and subsequently transferred to
CD1-deficient recipients. Since Cd1d1/ animals lack
endogenous NKT cells, we adoptively transferred
CFSE-labeled NKT cells from Va14-transgenic mice to
Immunity
Ito Cells Are Antigen-Presenting CellsFigure 1. Ito Cells Exhibit Traits of APCs and Express CD1d Molecules
(A) Ito cells display a star-shaped phenotype. Phase-contrast microscopy demonstrates the morphology of murine and human Ito cell preparations.
Inserts visualize lucent cytoplasmic lipid droplets at higher magnification.
(B) Ito cells are defined by the expression of GFAP. Ito cells were fixed, permeabilized, and stained with anti-GFAP. After incubation with a secondary
antibody coupled to Cy5, cells were analyzed by confocal microscopy. Right panels show Cy5-emitted fluorescence intensity and left panels repre-
sent phase-contrast images of the same cells.
(C) Flow cytometric analysis of APCmolecules expressed on Ito cells. Murine and human Ito cells were stained with antibodies against CD1d, MHC-II,
and CD86. Additionally, mouse Ito cells were stained with anti-CD11c, and human Ito cells were incubated with anti-CD1b. Histograms indicate in-
creases in fluorescence intensity resulting from specific surface molecule detection (black curves) compared to isotype controls (gray filled curves).
Data are representative of at least three independent experiments with similar results.CD1-deficient recipients in parallel with Ito cells. Because
CD1-deficient recipients fail to present lipids, any effect
of CD1d-restricted antigen presentation in this transfer
system cannot be attributed to any other cell than donor
Ito cells. 3 days after adoptive transfer, liver lymphocytes
from recipient mice were isolated and NKT cells were
identified with CD1d tetramers. Histograms in Figure 2C
demonstrate decrease of CFSE fluorescence intensity
indicating cell division of NKT cells gated on CD1d-
tetramer+ cells. Transfer of a-GalCer-pulsed Ito cellsfrom wild-type mice induced antigen-specific NKT cell
proliferation in vivo, whereas a-GalCer-pulsed Ito cells
from CD1-deficient animals failed to stimulate NKT cells
(Figure 2C). Thus, Ito cells exhibit APC function for NKT
cells in vivo.
Ito Cells Produce IL-15 for Homeostatic
NKT Cell Proliferation
Interleukin-15 (IL-15) plays an essential role in NKT cell,
NK cell, and memory CD8+ T cell survival (GrabsteinImmunity 26, 117–129, January 2007 ª2007 Elsevier Inc. 119
Immunity
Ito Cells Are Antigen-Presenting CellsFigure 2. Ito Cells Induce Vigorous CD1d-Restricted NKT Cell Responses
(A) Ito cells activate murine NKT cells in a CD1d-dependent fashion. Ito cells from wild-type (WT) or Cd1d1/ animals or DCs were pulsed with
a-GalCer (1 mg/ml) and cocultured with NKT cells from thymus, spleen, or liver from Va14-transgenic mice. Additionally, Ito cells or DCs were treated
with a CD1d-blocking antibody (10 mg/ml) before addition of T cells. 2 days after stimulation, antigen-specific proliferation was determined by
3H-thymidine incorporation as depicted by counts per minute (cpm) (error bars represent mean ± SD).
(B) HumanNKT cells are activated by Ito cells. Human Ito cells or DCswere incubated with a-GalCer (1 mg/ml) and exposed to a Va24+ humanNKT cell
line. In addition, Ito cells or DCs were incubated with a blocking antibody against human CD1d. 2 days after stimulation, antigen-specific proliferation
was determined by 3H-thymidine incorporation as depicted by counts per minute (cpm) (error bars represent mean ± SD).
(C) Ito cells perform APC function for NKT cells in vivo. Ito cells were generated fromwild-type (Cd1d1+/+) orCd1d1/mice and pulsed with a-GalCer
for 2 hr before intravenous injection into Cd1d1/ animals. In parallel, NKT cells from Va14 transgenic mice were purified, labeled with CFSE, and
adoptively transferred to Cd1d1/ recipients. 3 days after transfer, liver lymphocytes were prepared and stained for NKT cells with CD1d tetramers.
Histograms demonstrate the proliferation profiles of CFSE-labeled NKT cells gated on tetramer+ cells after transfer of antigen-loaded wild-type (top)
or Cd1d1/ Ito cells (bottom). Graphs in (A)–(C) are representative of at least three independent experiments with similar results.et al., 1994; Waldmann and Tagaya, 1999). Because IL-15
is critically required for NKT cell homeostasis (Matsuda
et al., 2002), we analyzed the impact of IL-15 on Ito cell-
mediated T cell activation. To this end,we added a neutral-
izing antibody against IL-15 to coculture assays of a-
GalCer-loaded Ito cells and NKT cells. Antigen-specific
proliferation of murine NKT cells in response to a-GalCer
presented by Ito cells was not reduced by IL-15 neutraliza-
tion (Figure 3A). Thus, IL-15 was not essential for antigen-
dependent NKT cell activation. However, murine NKT
cells reacted to unpulsed Ito cells with a distinct prolifera-
tive response. It is known that NKT cells are autoreactive
to CD1d in the absence of nominal antigen (Brigl and
Brenner, 2004). Addition of anti-IL15 to unpulsed Ito cells
markedly inhibited this autoreactive NKT cell response
(Figure 3A). Thus, IL-15 was critically required for Ito
cell-mediated homeostatic NKT cell proliferation. These120 Immunity 26, 117–129, January 2007 ª2007 Elsevier Inc.results were also valid for the human system with human
NKT cells and a neutralizing antibody against human
IL-15 (Figure 3A). T cells do not produce IL-15 (Grabstein
et al., 1994), so we analyzed Ito cells for IL-15 expression.
To this end, we performed real-time PCR to quantify IL-15
mRNA expression amounts in murine and human Ito cells
in comparison with primary mouse hepatocytes or the
human hepatic cell lines HEP-G2 and HEP-3B, respec-
tively. Moreover, cells were stimulated with the synthetic
double-stranded RNA poly[IC], a known inducer of IL-15
(Matsuda et al., 2002). Quantification of IL-15 mRNA re-
vealed that under steady-state conditions, murine and
human Ito cells expressed IL-15 (Figure 3B). In contrast,
primary liver cells or liver cell lines HEP-G2 (Figure 3B)
and HEP-3B (data not shown) did not express IL-15.
More importantly, IL-15 transcription was induced by
poly[IC] stimulation in murine and human Ito cells
Immunity
Ito Cells Are Antigen-Presenting CellsFigure 3. Ito Cells Express IL-15 to Facilitate Homeostatic NKT Cell Proliferation
(A) IL-15-dependent homeostatic proliferation of NKT cells. Murine and human Ito cells were pulsed with a-GalCer (1 mg/ml) or were left untreated
before addition of NKT cells. Additionally, blocking antibodies (10 mg/ml) to mouse or human IL-15 were added to Ito cells before coculture with
NKT cells. 2 days after stimulation, NKT cell proliferation was determined by 3H-thymidine incorporation as indicated by counts per minute (cpm)
(error bars represent mean ± SD). Graphs are representative of at least three independent experiments with similar results.
(B) Quantification of IL-15 expression by Ito cells. Murine Ito cells compared to primarymouse hepatocytes as well as human Ito cells compared to the
human hepatic cell line HEP-G2were stimulated with poly[IC] for 4 hr or were left untreated. After RNA preparation, real-time PCRwas performed with
primers specific for IL-15 and the housekeeping geneGAPDH. Quantification of IL-15mRNA expression standardized to GAPDH is shown as arbitrary
units (A.U. = 100,000 / fold difference) (error bars represent mean ± SD). *p < 0.05; **p < 0.01 as analyzed by Student’s t test.
(C) Ito cell-derived IL-15 promotes homeostatic NKT cell proliferation in vivo. Ito cells from wild-type or Il15/ mice were transferred to Il15/ re-
cipients. In parallel, NKT cells were isolated from Va14 transgenic thymi, labeled with CFSE, and injected into wild-type or Il15/mice. 10 days after
transfer, liver lymphocytes from recipient animals were isolated and stained with CD1d tetramer, and NKT cell division was analyzed by flow cytom-
etry. Decrease of CFSE fluorescence intensity indicates proliferation of transferred NKT cells gated on CD1d-tetramer+ cells.(Figure 3B), while parenchymal liver cells did not upregu-
late IL-15 transcription.
To analyze the impact of Ito cells on IL-15-dependent
homeostatic proliferation of NKT cells in vivo, we isolated
Ito cells from wild-type and Il15/ mice and transferred
them to IL-15-deficient recipients. In parallel, NKT cells
were purified from Va14-transgenic thymi, labeled with
CFSE, and injected into wild-type or IL-15-deficient
mice. 10 days after transfer, liver lymphocytes from recip-
ient animals were isolated and stained with CD1d tetra-
mers prior to flow cytometrical analysis. As demonstrated
by decrease of CFSE fluorescence intensity of CD1d-
tetramer+ cells, homeostatic proliferation of NKT cells
was prominent in livers of WT animals, but not in Il15/
mice (Figure 3C, left). Adoptive transfer of wild-type Ito
cells into IL-15-deficient mice induced NKT cell division
and restored homeostatic NKT cell proliferation as seen
in wild-type animals. Transfer of Il15/ Ito cells did not
have any effect on NKT cell proliferation (Figure 3C, right).
In conclusion, Ito cells express IL-15 to promote homeo-
static proliferation of NKT cells.Ito Cells Present Peptides to CD4+ and CD8+ T Cells
and Induce T Cell Priming In Vivo
Because we observed surface expression of MHC-I,
MHC-II, and costimulatory molecules by Ito cells (Fig-
ure 1C, Figure S1), which is in accordance with earlier re-
ports (Vinas et al., 2003; Yu et al., 2004), we aimed at elu-
cidating the functional significance with regard to CD8+
and CD4+ T cell stimulation. To this end, we isolated anti-
gen-specific CD8+ or CD4+ T cells from TCR-transgenic
mice (OT-1 or OT-2, respectively). OT-1 or OT-2 lympho-
cytes were purified by positive selection of CD8+ or
CD4+ cells, respectively, and purity of >95%of T cell prep-
arations was confirmed by flow cytometry. Ito cells and
DCs were pulsed with ovalbumin or ovalbumin-derived
antigenic peptides that are specifically recognized by
OT-1 or OT-2 T cells and subsequently cocultured with
CD8+ or CD4+ T cells. CD8+ T cells were specifically stim-
ulated by Ito cells presenting the ovalbumin peptide SIIN-
FEKL in the context ofMHC-I (Figure 4A). Similarly, CD4+ T
cells were stimulated by the ovalbumin epitope ISQAV in
the context of MHC-II (Figure 4A). Ito cells processedImmunity 26, 117–129, January 2007 ª2007 Elsevier Inc. 121
Immunity
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sponses Specific for Protein Antigens
(A) Ito cells present peptide to CD8+ or CD4+ T
cells andprocess exogenous antigen for cross-
priming ofCD8+ T cells. Ito cells or DCswere in-
cubated with SIINFEKL (SIINF, 1 mg/ml), ISQAV
(1 mg/ml), or ovalbumin (Ova, 5 mg/ml) or were
left untreated. Subsequently, antigen-pulsed
Ito cells or DCs were cocultured with CD8+ T
cells (OT-1) or CD4+ T cells (OT-2). Additionally,
OT-1 and OT-2 T cell preparations were incu-
bated with ovalbumin (5 mg/ml) alone. 2 days
after stimulation, antigen-specific proliferation
was analyzed by 3H-thymidine incorporation
as indicated by counts per minute (cpm) (error
bars represent mean ± SD). Graphs are representative of at least three independent experiments with similar results.
(B) Ito cells induce T cell priming in vivo. 13 106 Ito cells or DCs from wild-type or B2m/mice were loaded with the whole ovalbumin protein before
intravenous injection into B2m/ recipients. In parallel, 53 106 to 13 107 purified CFSE-labeled CD8+ OT-1 cells were transferred. 5 days later, liver
lymphocytes were isolated and stained for CD8. Dot plots depict CFSE dilution of CD8+ cells.the entire ovalbumin protein for antigen-specific CD4+ T
cell stimulation. More importantly, Ito cells processed ov-
albumin for CD8+ T cell stimulation, revealing their capac-
ity for crosspresentation (Figure 4A). In conclusion, Ito
cells efficiently present peptides to CD8+ and CD4+ T cells
and process exogenous antigen for crosspriming of CD8+
T cells. Direct pulsing of CD4+ or CD8+ T cells with ovalbu-
min in the absence of Ito cells did not result in proliferation
excluding direct antigen presentation by T cells or by con-
taminating APCs from primary T cell preparations (Fig-
ure 4A). In addition, we analyzed IFNg concentrations in
cell-culture supernatants from experiments described
above by ELISA. CD8+ as well as CD4+ T cells secreted
IFNg in an antigen-specific manner, indicating functional
differentiation of T cells upon Ito cell-mediated activation
(Figure S3C). Furthermore, we askedwhether CD8+ T cells
activated by Ito cells develop fully competent cytotoxic
function. To this end, 51Cr-labeled Ito cells pulsed with
SIINFEKL peptide or left untreated were incubated with
OT-1 cells, and 51Cr-release was measured in cell-culture
supernatants (Figure S3D). Indeed, CD8+ T cells activated
by Ito cells developed CTL function as demonstrated by
target cell lysis and subsequent 51Cr release.
In order to analyze the capacity of Ito cells for priming of
peptide-specific T cells in vivo, we pulsed Ito cells or DCs
isolated from wild-type or Beta2-microglobulin (B2m)-de-
ficient mice with ovalbumin before intravenous injection
into B2m/ recipients. Because B2m/ mice lack sur-
face-expressed MHC-I molecules as well as CD8+ T cells,
we transferred purified CFSE-labeled CD8+ OT-1 cells in
parallel. 5 days after transfer, lymphocytes from liver and
spleen were isolated and stained for CD8. Flow cytometric
analysis indicated T cell activation after transfer of anti-
gen-loaded Ito wild-type cells in contrast to B2m/ Ito
cells (Figure 4B, left). Ito cell-induced T cell priming was
comparable to the effect of DCs (Figure 4B, right). Be-
cause B2m-deficient mice lack surface-expressed MHC-I
molecules for antigen presentation, any effect of MHC-I-
restricted T cell activation in B2m-deficient recipients
was due to priming by Ito cells. Thus, crosspresentation
of antigen by other endogenous APC types can be ex-122 Immunity 26, 117–129, January 2007 ª2007 Elsevier Inc.cluded in this transfer system. In conclusion, Ito cells rep-
resent professional APCs able to present peptides to
CD8+ and CD4+ T cells, to process exogenous antigen
for crosspriming of CD8+ T cells, and to induce T cell
priming in vivo.
Bacterial Antigens Are Processed by Ito Cells
for Presentation to CD8+ T Cells upon Infection
To analyze whether Ito cells induce antigen-specific CD8+
T cell responses after infection with intracellular bacteria,
we incubated Ito cells with recombinant Listeria mono-
cytogenes expressing the surrogate antigen ovalbumin
(L.m.-OVA). L. monocytogenes is taken up by target cells
through induced phagocytosis and subsequently escapes
from the phagosome upon forming membrane pores by
means of listeriolysin O (Beauregard et al., 1997). Then,
bacterial antigens reach the cytosol for processing
through the MHC-I pathway and subsequent CD8+ T
cell activation. After infection of murine Ito cells with
L.m.-OVA at a multiplicity of infection (moi) of 4 for 30
min, extracellular bacteria were killed by gentamycin.
Subsequently, CFSE-labeled OT-1 cells were cocultured
with infected or noninfected Ito cells. After 3 days, cells
were stained with anti-CD8 and analyzed by flow cytome-
try. Infected Ito cells induced antigen-specific CD8+ T cell
proliferation, indicated by CFSE dilution of CD8+ OT-1
cells as compared to coculture with noninfected Ito cells
(Figure 5A). In conclusion, Ito cells are able to process
bacterial antigens for presentation to CD8+ T cells.
Ito Cells Mediate Protection against Infection
with Intracellular Bacteria
To examine the role of Ito cells in infection in vivo, we
transferred antigen-loaded (OVA) or unloaded Ito cells or
DCs to recipient wild-type mice. 1 week later, animals
were challenged with 5 3 104 to 1 3 105 L.m.-OVA intra-
venously. 48 hr after infection, spleen and liver were
collected for tetramer analysis of peptide-specific T cell
expansion, and bacterial load was determined by count-
ing colony-forming units (CFU). Antigen-loaded Ito cells
markedly increased the frequency of peptide-specific
Immunity
Ito Cells Are Antigen-Presenting CellsFigure 5. Upon Infection, Ito Cells Elicit
Peptide-Specific T Cells and Mediate
Protection In Vivo
(A) Ito cells stimulate antigen-specific CD8+ T
cells after infection with intracellular bacteria.
Ito cells were infected with L.m.-OVA at a moi
of 4 for 30 min, and subsequently, extracellular
bacteria were killed with gentamycin. CFSE-la-
beled OT-1 cells were added and incubated for
3 days. Cells were stained with anti-CD8 and
analyzed by flow cytometry. Dot plots depict
CD8 staining of CFSE-labeled OT-1 cells in
the presence of infected or noninfected Ito
cells. Histogram represents overlay of prolifer-
ation profiles (black line, Ito infected; gray-filled
curve, Ito noninfected).
(B) In vivo, Ito cells elicit peptide-specific T
cells and protect against bacterial infection.
Antigen-loaded (OVA) or unloaded Ito cells
or DCs were transferred to recipient mice.
1 week later, animals were intravenously
infected with 5 3 104 to 1 3 105 L.m.-OVA.
48 hr after infection, spleen and liver were
collected for analysis of the frequency of SIINFEKL-specific CD8+ T cells by flow cytometry and determination of bacterial burdens by counting
CFU (middle panel, 4 mice per group, error bars represent mean ± SD). Percentages of SIINFEKL-specific CD8+ T cells are depicted in the quadrants
of dot plots. Graphs in (A) and (B) are representative of at least three independent experiments with similar results.CD8+ T cells in spleen, as revealed by staining with SIIN-
FEKL-loaded MHC-I tetramers (Figure 5B). In contrast to
unpulsed cells, antigen-loaded Ito cells induced reduction
of bacterial burden in the liver (Figure 5B). Thus, Ito cells
elicit peptide-specific T cells and protect against bacterial
infection in vivo.
Transgenic Ito Cells Present Endogenous
Neoantigen to Peptide-Specific T Cells
Because analyzing APC function of Ito cells relied on load-
ing of exogenous antigen, we next addressed the question
of intrinsic antigen presentation by Ito cells in vitro and
in vivo. To this end, we used transgenic mice expressing
the neoantigen hemagglutinin (HA) from influenza virus un-
der the control of the GFAP promoter (GFAP-HA) (Morgan
et al., 1996; Cornet et al., 2001). Because in the liver GFAP
is exclusively produced by Ito cells, we isolated Ito cells
from GFAP-HA transgenic mice in order to analyze HA ex-
pression. RT-PCR revealed expression of HA mRNA in Ito
cells from transgenic but not from wild-type mice (Fig-
ure 6A). In order to examine the functional impact of en-
dogenous neoantigen expression by Ito cells on T cell ac-
tivation, we performed an in vitro assay with Ito cells from
GFAP-HA or wild-type mice in coculture with HA-specific
TCR-transgenic CD8+ T cells (CL4). GFAP-HA Ito cells
induced profound activation of HA-specific CD8+ T cells
as indicated by antigen-specific proliferation (Figure 6B).
CD8+ T cell activation was dependent on MHC-I-
restricted antigen presentation because addition of an
MHC-I blocking antibody totally abrogated the T cell re-
sponse (Figure 6B). In marked contrast, Ito cells from
wild-type animals did not activate HA-specific CD8+ T
cells (Figure 6C). However, after pulsing with different
concentrations of HA peptide, wild-type Ito cells causedMHC-I-restricted T cell activation in a dose-dependent
manner (Figure 6C). In conclusion, transgenic Ito cells
from GFAP-HA mice present intrinsic neoantigen for sub-
sequent T cell activation.
In order to investigate presentation of intrinsic antigen
by Ito cells in vivo, we conducted adoptive transfers of
CFSE-labeled HA-specific CD8+ T cells to GFAP-HA
transgenic or wild-type recipient mice. 3 days after trans-
fer, liver lymphocytes were purified for subsequent CD8
staining and measurement of proliferation profiles by
flow cytometry. Transfer of HA-specific CD8+ T cells
(CL4) to GFAP-HA recipient mice caused activation of
lymphocytes from liver, as indicated by decrease of
CFSE fluorescence intensity (Figure 6D, top). This activa-
tion can already be observed as early as 40 hr after trans-
fer (data not shown). Unspecific activation of T cells was
excluded by CL4 transfer to wild-type recipients showing
lack of CD8+ T cell proliferation in hepatic tissue (Fig-
ure 6D, bottom). Staining of lymphocytes from recipient
mice by HA-loaded MHC-I-tetramers revealed increased
frequency of HA-specific T cells from GFAP-HA trans-
genic livers when compared to wild-type as well as trans-
genic spleen, indicating preferential accumulation of pep-
tide-specific T cells in GFAP-HA liver (Figure 6E). In
parallel, we analyzed liver sections of recipient mice for
the anatomical distribution of transferred CD8+ T cells in
relation to HA-presenting Ito cells in situ. After staining
endogenous Ito cells for the liver-specific Ito marker
molecule GFAP, fluorescence microscopy demonstrated
clustering of CFSE+ CD8+ T cells in association with
Ito cells when HA-specific T cells were transferred to
GFAP-HA transgenic but not to wild-type mice (Fig-
ure 6F). Taken together, endogenous Ito cells present
intrinsic antigen for subsequent T cell activation in vitro
and in vivo.Immunity 26, 117–129, January 2007 ª2007 Elsevier Inc. 123
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(A) Ito cells from GFAP-HA transgenic mice express hemagglutinin (HA). Total RNA was isolated from GFAP-HA transgenic (GFAP-HA) or wild-type
(WT) Ito cells and analyzed by RT-PCR for HA expression. Depicted are PCR products amplified with HA- and GAPDH-specific primers. Reverse
transcription (cDNA), RT minus control (RT).
(B and C) Transgenic Ito cells present intrinsic antigen to peptide-specific T cells in vitro.
(B) Ito cells from GFAP-HA mice were cocultured with HA-specific CD8+ T cells (CL4).
(C) In parallel, Ito cells fromwild-typemicewere coculturedwith CL4 T cells. Peptide pulsing of Ito cells was performedwith different concentrations of
HA peptide before coculture with T cells.
(B and C) Blocking antibodies to MHC-I (20 mg/ml) or isotype controls were added before incubation. 2 days after stimulation, antigen-specific pro-
liferation was analyzed by 3H-thymidine incorporation as indicated by counts per minute (cpm) (error bars represent mean ± SD).
(D) HA-specific T cells from liver show activation in GFAP-HA mice in vivo. HA-specific CD8+ T cells from CL4-TCR transgenic spleen were purified,
CFSE labeled, and intravenously transferred to GFAP-HA transgenic (GFAP-HA, top) or wild-type (WT, bottom) mice. 3 days after transfer, liver lym-
phocytes were purified and stained for CD8 prior to flow cytometric analysis. Histograms depict CFSE dilution gated on CD8+ cells.
(E) HA-specific T cells preferentially accumulate in GFAP-HA liver. In parallel to (D), lymphocytes from liver and spleen were stained with HA-peptide-
loaded MHC-I tetramers and anti-CD8. Depicted are percentages of tetramer+ among CD8+ T cells in spleens and livers of wild-type and GFAP-HA
mice.
(F) Antigen-specific T cells cluster aroundHA-presenting Ito cells in situ. As per an analogous experimental set-up as under (D), livers of T cell recipient
animals were excised, and cryosections were stained for GFAP prior to fluorescencemicroscopy analysis. Overlays of CFSE+ HA-specific T cells and
GFAP-expressing Ito cells are shown for GFAP-HA transgenic (GFAP-HA) and wild-type (WT) livers. Graphs in (A)–(F) are representative of at least two
independent experiments with similar results.DISCUSSION
It has been shown recently that liver is an efficient and self-
sufficient priming site for naive CD8+ T cells independently
of secondary lymphoid organs or bone marrow-derived
APCs (Klein and Crispe, 2006). However, in these elegant
studies, the cellular basis of intrahepatic antigen presenta-
tion has not been addressed. In earlier reports, several
liver cell types have been implicated in induction of T124 Immunity 26, 117–129, January 2007 ª2007 Elsevier Inc.cell tolerance (Crispe, 2003). In contrast, our data identify
Ito cells as professional intrahepatic APCs activating T
cells and eliciting a multitude of T cell responses specific
for protein and lipid antigens.
Proof of APC function of Ito cells relies on purity of both
Ito cell and T cell preparations to exclude T cell activation
by contaminating APCs. Purity of Ito cell preparations was
determined as R98.5% by a combination of positive
GFAP staining (Neubauer et al., 1996) and negative
Immunity
Ito Cells Are Antigen-Presenting CellsCD11c and F4/80 staining excluding the presence of addi-
tional APCs known to elicit T cell responses. Functional
impact of potentially contaminating APCs in primary T
cell preparations was excluded by lack of activation
when T cells were stimulated with antigen alone in the
absence of Ito cells.
With regard to group II CD1 antigen presentation, we
demonstrate vigorous NKT cell activation by human and
murine Ito cells in a CD1d-restricted manner. Ito cells per-
formed professional APC functions for NKT cells compa-
rable to those of DCs in vitro and induced NKT cell prolif-
eration in vivo when transferred from wild-type into
Cd1d1/ mice, excluding contribution of any other APC
in recipient mice. NKT cells account for up to 50% of liver
lymphocytes; however, the factors rendering liver tissue
a preferential location for NKT cells remained elusive (Kro-
nenberg and Gapin, 2002). Different liver cell types capa-
ble of presenting the surrogate antigen a-GalCer have
been implicated in NKT cell activation (Bezbradica et al.,
2005; Schmieg et al., 2005). It has been shown recently
that >90% depletion of Kupffer cells reduced the percent-
age of IFNg- or IL-4-producing liver NKT cells when
a-GalCer was injected 2 hr before cytokine measurement
(Schmieg et al., 2005). In this work, depletion of Kupffer
cells by injection of clodronate-liposomes has not been
monitored for its effect on phagocytic Ito cells. Thus, de-
creased numbers of responsive NKT cells cannot be at-
tributed solely to depletion of Kupffer cells. Furthermore,
the NKT cell restriction element CD1d is expressed only
at very low amounts on Kupffer cells compared to Ito cells,
and hence Ito cells appear superior for CD1d-mediated
antigen presentation (see Supplemental Data).
IL-15 is a crucial cytokine in survival of NKT cells, as in-
dicated by lack of NKT cells in IL-15 and IL-15 receptor-
deficient animals (Kennedy et al., 2000; Lodolce et al.,
1998). Our data demonstrate that hepatic Ito cells produce
IL-15, facilitating homeostatic NKT cell proliferation. Thus,
Ito cells induce both CD1d-restricted, antigen-dependent
and homeostatic, IL-15-dependent NKT cell proliferation.
Although we do not exclude contribution of other liver cell
types to NKT cell homeostasis, our findings shed light on
the enigma of NKT cell abundance in the liver with the Ito
cell providing the crucial environment for NKT cell expan-
sion.
In addition to group II CD1 molecules, human Ito cells
expressed CD1b molecules at high surface density. So
far, surface expression of group I CD1 molecules has
been exclusively confined to DCs (Brigl and Brenner,
2004). Moreover, Ito cells vigorously stimulated T cell
clones specifically recognizing the lipid lipoarabino-
mannan (LAM) when pulsed with sonicate fromMycobac-
terium leprae in a CD1b-restricted fashion (see Supple-
mental Data). Thus, human Ito cells present lipids of
microbial origin to T cells, demonstrating functional signif-
icance of CD1b expression on Ito cells comparable to
DCs.
Expression of APC markers by Ito cells and presen-
tation of peptide antigens to CD4+ and CD8+ T cells dem-
onstrate that Ito cells are capable of stimulating protein-specific T cells. Transfer of antigen-loaded Ito cells and
CD8+ T cells into B2m-deficient mice provided a model
that lacks endogenous MHC-I-restricted antigen presen-
tation. Activation of peptide-specific T cells in recipient
B2m-deficient mice excluded crosspresentation of anti-
gen by other endogenous APCs and demonstrated pro-
found priming capacity of Ito cells in vivo. Moreover, Ito
cells processed exogenous protein antigens for subse-
quent activation of CD8+ T cells, a mechanism referred
to as crosspresentation characterizing professional APC
function (Ackerman and Cresswell, 2004; Winau et al.,
2005a). Thus, Ito cells can mediate surveillance of the ex-
tracellular space for antigens by transporting proteins into
theMHC-II as well as theMHC-I pathway for broad activa-
tion of CD4+ and CD8+ T cells.
To investigate APC functions of Ito cells in infection im-
munology, we analyzed the impact of Ito cells upon infec-
tion with the intracellular pathogen L. monocytogenes
(Pamer, 2004). In vitro, Ito cells processed bacterial anti-
gens for subsequent MHC-I presentation and CD8+ T
cell activation. In vivo, Ito cells elicited peptide-specific
T cells and mediated protection against infection with
L. monocytogenes comparable to the effect of DCs. The
majority of pathogens targeting hepatocytes have to cross
the perisinusoidal space of Disse, so Ito cells adjacent to
hepatocytes are located at a privileged site to sense path-
ogens attacking liver parenchyma.
To study intrinsic antigen presentation by Ito cells, we
extended our experiments with transgenic mice express-
ing the neoantigen hemagglutinin under the GFAP pro-
moter (Morgan et al., 1996), which in the liver is exclusively
active in Ito cells (Neubauer et al., 1996). GFAP-HA trans-
genic Ito cells express hemagglutinin for presentation to
antigen-specific T cells. In vivo HA-specific T cells isolated
from liver tissue of GFAP-HA mice were activated as indi-
cated by antigen-specific T cell proliferation. Moreover,
HA-specific T cells accumulated in GFAP-HA transgenic
liver when compared to spleen. Although we cannot
formally exclude stimulation of HA-specific T cells in ex-
trahepatic tissue of GFAP-HA mice, histological analysis
of liver revealed clustering of HA-specific T cells around
HA-presenting Ito cells. Taken together, our data indicate
that endogenous Ito cells present intrinsic antigen to T
lymphocytes in situ.
Different cell types have been implicated in intrahepatic
antigen presentation, namely liver sinusoidal endothelial
cells (LSEC), Kupffer cells, and hepatocytes. LSECs pos-
sibly can present exogenous antigens, but induce T cell
tolerance (Katz et al., 2004; Knolle and Gerken, 2000;
Limmer et al., 2000). Kupffer cells have been shown to
be capable of presenting antigens, but are markedly less
efficient than splenic macrophages (Roland et al., 1994).
Furthermore, Kupffer cells appear to be negative regula-
tors of T cell activation by paracrine factors in a complex
interplay with LSECs (Knolle and Gerken, 2000). Hepato-
cytes can induce short-term proliferation of CD8+ T cells
but lead to premature T cell death, possibly caused by
a lack of costimulatory molecules such as CD86 (Bertolino
et al., 1999, 2001). Our data qualify Ito cells as APCsImmunity 26, 117–129, January 2007 ª2007 Elsevier Inc. 125
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contrast to Kupffer cells, which are locatedwithin the sinu-
soidal compartment, Ito cells are localized in the perisinu-
soidal space of Disse adjacent to hepatocytes (Geerts,
2001). Although LSECs separate the space of Disse
from the sinusoidal space, this barrier is incomplete be-
cause it lacks a basement membrane, does not have tight
junctions, and underlies dynamic changes by the forma-
tion of fenestrae and sieve plates (Braet and Wisse,
2002). Since lymphocytes can be found in the liver paren-
chyma, diapedesis and transit of cells through the space
of Disse demonstrates that the sinusoidal barrier is pene-
trable. Thus, Ito cells may function as professional APCs
for activation or restimulation of T cells contacting sub-
endothelial compartments either under physiological con-
ditions through incomplete compartment separation or
under pathological conditions when this barrier is disinte-
grated. In this context, Ito cells appear to be located at a
privileged site and may act as resident sentinels of liver
parenchyma.
So far, Ito cells were known for storage of retinol (vita-
min A), which is critical for immune function and mainte-
nance of gut integrity (Stephensen, 2001). Moreover, it
has been demonstrated that T cells stimulated in the pres-
ence of the retinol metabolite retinoic acid upregulate gut
homing receptors a4b7 and CCR9 (Iwata et al., 2004).
DC-derived retinoic acid increased T cell tropism to small
intestine, whereas vitamin A deficiency resulted in deple-
tion of T cells from intestinal lamina propria. Ito cells store
up to 80% of total body retinol, so it is tempting to specu-
late on a dual role for Ito cells in both antigen presentation
and regulation of T cell tropism.
Ito cells have also been located in extrahepatic tissues
including pancreas, intestine, and lung (Nagy et al.,
1997). Assuming that extrahepatic Ito cells perform anti-
gen-presenting functions comparable to that of intra-
hepatic Ito cells shown here, we propose that Ito cells rep-
resent tissue-resident professional APCs, which elicit T
cell responses and serve as target cells in situ within the
scope of a systemic Ito network.
EXPERIMENTAL PROCEDURES
Experimental Animals and Cell Lines
6- to 8-week-old C57BL/6, Balb/c, OT-1, OT-2, Va14-Ja18 transgenic,
Cd1d1/, B2m/, Il15/, GFAP-HA transgenic, and CL4 TCR trans-
genic mice were bred under specific pathogen-free conditions. OT-1
and OT-2 breeder mice were obtained from Jackson Laboratories.
Va14-Ja18 transgenic and Cd1d1/ breeders were kindly provided
by A. Bendelac, Princeton. Human NKT cell lines were kindly provided
by E. Scotet and M. Bonneville, Nantes. In brief, peripheral blood lym-
phocytes from healthy human donors were sorted for Va24+ cells and
were subsequently expanded with PHA, IL-2, and irradiated feeder
cells. The CD1b-restricted T cell line LCD4.7 reactive with LAM from
M. lepraewas described previously (Sieling et al., 2000). Human hepa-
tocellular carcinoma cell lines HEP-G2 and HEP-3B were from ATCC.
All material was used in accordance with the local ethics commission.
Preparation of Ito Cells
Ito cells were prepared from liver of C57BL/6, Balb/c, Cd1d1/,
Il15/, and GFAP-HA transgenic mice. In brief, the abdominal cavity126 Immunity 26, 117–129, January 2007 ª2007 Elsevier Inc.of anesthetized animals was opened to canulate the portal vein. Sub-
sequently, liver was perfused for 5 min with solution SC-1, 4 min with
solution SC-2, 4 min with 0.5 mg/ml pronase solution, and 4 min with
0.25 mg/ml collagenase solution at a flow rate of 6 ml/min (Kristensen
et al., 2000). After perfusion, tissuewas further digested in 120ml SC-2
solution supplemented with 50 mg collagenase, 50 mg pronase, and
2 mg DNase. After digestion, the cell suspension was passed through
a nylon mesh and centrifuged at 400 3 g for 10 min. Subsequently,
cells were purified through 8% Nycodenz (Axis-Shield PoC) gradient
centrifugation. Ito cells were grown in DMEM medium (GIBCO-BRL)
containing 5% FCS for 3 days before experiments were performed.
Cells were recovered by mild trypsinization or detachment via
Accutase (PAA, Austria). Human Ito cells were obtained from liver
specimens of patients undergoing liver needle biopsy for diagnosis
of hepatic diseases. Material was used in accordance with the local
ethics commission. Surfacemarker expression and stimulatory capac-
ity varied between Ito cells from different donors. Ito cells were estab-
lished by outgrowth from explants placed in Opti-MEM-1 (GIBCO-
BRL) containing 5% FCS and 5% pooled human AB serum. Cells
were recovered by mild trypsinization or detachment via Accutase
and used for experiments between passages 3 and 6. Purity of Ito
cell preparations was >98.5% as confirmed by positive staining for
GFAP, a specific marker for hepatic Ito cells, and negative staining
for CD11c and F4/80. Mouse Kupffer cell preparations were pur-
chased from Dominion Pharmakine.
Antibodies, Antigens, and Chemicals
We used antibodies against murine CD86 (GL1) and CD11c (N418)
from Becton Dickinson (BD), MHCII (TIB120) and F4/80 (HB-198)
from ATCC, and CD1d (20H2) kindly provided by A. Bendelac, Prince-
ton. Antibodies to human CD1b (MT-101), CD1d (CD1d24), HLA-DR
(L243), CD86 (FUN-1), and CD40 (5C3) were purchased from BD.
Blocking antibodies against human CD1b (BCD1b) and CD1c (21A3)
were purified from hybridoma supernatants. Polyclonal antibodies to
human and mouse IL-15 were purchased from Abcam. Antibody to
mouse CD8a (YTS 169.4) was purified from hybridoma supernatants
with protein G-sepharose and conjugated with Cy5 according to stan-
dard protocols. Antibody cocktail to human and murine GFAP (4A11,
1B4, 2E1) was from BD. All fluorochrome-conjugated secondary
antibodies and isotype controls were purchased from BD. Listeria
antibody was from ATCC (43251). We used a mouse monoclonal anti-
body against HA (clone 37.38). For intracellular staining, Cytofix/
Cytoperm and Perm/Wash reagents from BD were used. Synthetic
peptides SIINFEKL (OVA257-264), and ISQAVHAAHAEINEAGR (ISQAV,
OVA323-339) were purchased from Jerini BioTools. HA-peptide
(512-520) was purchased from Neosystem Laboratory. Ovalbumin,
phytohemagglutinin (PHA), and poly[IC] were purchased from Sigma.
a-GalCer was kindly provided by Pharmaceutical Research Laborato-
ries, Kirin Brewery. Mouse recombinant IFNg was purchased from
Strathmann Biotech. Mycobacterial lipids were obtained from
M. leprae as described previously (Sieling et al., 2000).
Generation of DCs
For mouse DCs, bone marrow cells were prepared from femora of
C57BL/6 mice and plated in cell-culture dishes in complete DMEM
medium at 37C for 2 hr. Nonadherent cells were collected and cul-
tured in medium in the presence of GM-CSF (20 ng/ml, Strathmann)
for 10 days. For human DCs, monocytes from peripheral blood were
isolated by Ficoll gradient. Cells were plated in cell-culture dishes in
PBS for 2 hr and washed, and adherent cells were cultured in complete
RPMI medium in the presence of recombinant IL-4 and GM-CSF
(200 U/ml; Strathmann) for 6 days.
Phase-Contrast and Confocal Microscopy
Phase-contrast microscopy was performed on Ito cells examined in
culture flasks with a Leica DM IRBEmicroscope. For confocal analysis,
Ito cells were grown on multichambered slides (Nalgene Nunc)
for 2 days before fixation with 4% paraformaldehyde overnight.
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TritonX-100 for 5 min, and unspecific antibody binding was blocked
with PBS containing 5% FCS, 1% Fc-receptor block, and 0.05%
Tween20. Subsequently, Ito cells were incubated with antibodies for
30 min and washed five times with PBS. Slides were embedded with
Immumount (Dako) and sealed with coverslips. Staining was visualized
with a Leica TCS-NT confocal microscope.
FACS Analysis
Ito cells were detached from culture flasks by mild trypsinization or
treatment with Accutase and resuspended in FACS buffer (PBS, 1%
FCS, 0.05% NaN3). Cells were incubated with antibodies described
above at 4C for 30 min. Subsequently, Ito cells were washed in
FACS buffer and analyzed with a FACSCalibur flow cytometer (BD).
T Cell Assays
Thymus and spleen NKT cells were isolated from Va14-Ja18 trans-
genic mice. Organs were excised and single-cell suspensions were
prepared with a sieve before erythrolysis and resuspension of cells
in complete medium. To obtain hepatic NKT cells, liver was perfused
with PBS through the portal vein, removed, and homogenized with
a mesh. Cell suspensions were washed with medium and centrifuged
at 503 g for 2min, and the supernatants were collected. This step was
repeated four times. Cells from pooled supernatants were further
purified by a 40%/70% Percoll gradient. NKT cells were negatively
selected by depletion of CD8+ T cells with anti-CD8 microbeads and
separation on MACS columns (Miltenyi Biotec) as described previ-
ously (Matsuda et al., 2002). OT-1, OT-2, and CL4 lymphocytes were
prepared from mesenteric lymph nodes or spleen of OT-1, OT-2, or
CL4 mice, respectively. T cells were positively selected with anti-
CD4 or anti-CD8microbeads and separated onMACS columns. Purity
of cell isolations used was >95%. For T cell proliferation assays, 2.53
104 Ito cells were seeded in triplicates in 96-well round-bottom plates.
Antigens and blocking antibodies were added as indicated 1 hr before
addition of T cells at the following concentrations: 1 mg/ml a-GalCer,
10 mg/ml anti-IL-15, 10 mg/ml anti-CD1d, 1 mg/ml SIINFEKL, 1 mg/ml
ISQAVHAAHAEINEAGR, 5 mg/ml ovalbumin, 1 mg/ml PHA, and 0.1–
1 mg/ml HA peptide. NKT, OT-1/OT-2, or CL4 cells were added at a
concentration of 5 3 104 to 1 3 105 cells per well in a final volume of
200 ml complete DMEM medium and plates were incubated at 37C
and 5% CO2. On day 2, supernatant aliquots were collected for mea-
surement of IFNg and cells were pulsed with 0.5 mCi/well 3H-thymidine
(Amersham). 18 hr later, cells were collected for radioactivity measure-
ment on a Top Count scintillation counter (Packard). Mouse and hu-
man IFNg ELISA (Biosource International) was performed according
to the manufacturers’ protocol. 51Cr-release cytotoxicity assay was
performed as described before (Winau et al., 2005b).
RT-PCR
For IL-15 and HAmRNA quantification, total RNAwas isolated with the
High Pure RNA Extraction Kit (Roche) or Trizol (Invitrogen) followed by
DNase digestion (Roche). cDNA was synthesized with the SuperScript
III First-Strand Synthesis System and random hexamer primers (Invi-
trogen). RT-PCR was performed in triplicates with the ABIPRISM
SDS 7000 system (Applied Biosystems). Mouse (m) and human (h)
IL-15-, HA-, and GAPDH-specific cDNA fragments were amplified
with the SYBR Green I Reaction Mix (Roche) and primers hGAPDH-
For2 (GGA GTC AAC GGA TTT GGT CGT), hGAPDH-Rev2 (ACG
GTG CCA TGG AAT TTG C), hIL-15-For2 (TCA CCC CAGT TGC AAA
GTA ACA), hIL-15-Rev2 (TTC CTC ACA TTC TTT GCA TCC A),
mGAPDH-For1 (AGC CTC GTC CCG TAG ACA AAA), mGAPDH-
Rev1 (TGG CAA CAA TCT CCA CTT TGC), mIL-15-For1 (GAG GAA
TAC ATC CAT CTC GTG C), mIL-15-Rev1 (CCT ACA CTG ACA CAG
CCC AAA A), HA-For2 (AAA GAA AGC TCA TGG CCC AA), and
HA-Rev2 (TCT CCG TCA GCC ATA GCA AAT). Threshold cycle values
CT for target- and GAPDH-specific fragment amplification were deter-
mined with ABIPRISM SDS7000 software, and delta-CT values were
calculated. Fold difference (FD) in expression amounts betweenIL-15 and GAPDH was calculated according to the formula FD =
2(deltaCT
). Relative quantification of IL-15 expression standardized to
GAPDH is expressed as arbitrary units (A.U. = 100,000 / FD). RT-PCR
products were resolved on 3% agarose gels.
Adoptive Transfer of Ito, NKT, and CD8+ T Cells
1 3 106 Ito cells generated from wild-type or Cd1d1/ mice were
incubated with 1 mg/ml a-GalCer for 2 hr. After extensive washing,
Ito cells were injected into the lateral tail vein of Cd1d1/ recipients.
NKT cells were purified from thymus of Va14-Ja18 transgenic animals
prior to labeling with 5 mMCFSE (Molecular Probes) in PBS for 5 min at
RT. Subsequently, NKT cells were washed, resuspended in PBS, and
intravenously transferred to Cd1d1/ recipient mice. 3 days after
transfer, NKT cells from liver were isolated and stained with CD1d tet-
ramers prior to analysis of CFSE dilution by flow cytometry. TCR trans-
genic CD8+ T cells were positively selected from spleen of CL4mice by
CD8 microbeads. After CFSE labeling, 5 3 106 CL4 cells were intra-
venously injected into GFAP-HA or Balb/c mice. 3 days after transfer,
CL4 cells were isolated from liver and spleen, stained for CD8, and an-
alyzed by flow cytometry. OT-1 cells were prepared from mesenteric
lymph nodes of OT-1 mice. After CFSE labeling, 5 3 106 to 1 3 107
OT-1 cells were intravenously injected into B2m/ animals.
Tetramer Analysis
Tetramers were constructed and loaded with antigens as described
(Matsuda et al., 2000). For flow cytometric analysis, 1 3 106 cells
were incubated for 15 min at 4C with polyclonal rat antibody, anti-
CD16/CD32, and streptavidin (Molecular Probes) in PBS containing
0.5% BSA and 0.01% sodium azide. After incubation, cells were
stained for 60 min at 4C with PE-conjugated a-GalCer-loaded
CD1d-tetramers, SIINFEKL-, or HA-peptide-loaded MHC-I tetramers.
Subsequently, cells were washed with PBS including 0.5% BSA and
0.01% sodium azide. Propidium iodide was added shortly prior to
FACS analysis.
Bacterial Infection and CFU
Listeria monocytogenes strain EGD expressing ovalbumin (L.m.-OVA)
was grown overnight in tryptic soy broth (TSB), washed in PBS,
aliquoted in PBS/10% glycerol, and stored at 80C. Then, aliquots
were thawed and bacterial titers were determined by plating serial di-
lutions on TSB agar plates. For in vitro infection, Ito cells were seeded
in 96-well plates at a concentration of 1 3 104 cells/well in 200 ml
DMEM andwere infected with L.m.-OVA at amoi of 4. After 30min, ad-
herent and extracellular bacteria were killed with gentamycin (5 mg/ml).
Ito cells were incubated for 24 hr, and CFSE-labeled OT-1 lympho-
cytes were added at a concentration of 13 105/well. After 3 days, cells
were stained with CD8 mAb and proliferation was analyzed by FACS.
For in vivo infection, listeria (5 3 104 to 13 105) were injected in a vol-
ume of 200 ml PBS into the lateral tail veins of mice 7 days after adop-
tive transfer of antigen-loaded (OVA) or unloaded Ito cells or DCs.
Liver and spleen were homogenized 48 hr after infection in PBS for
determination of bacterial burdens. Serial dilutions of homogenates
were plated on TSB agar plates and colonies were counted after
incubation at 37C overnight.
Statistical Analysis
Student’s t test was used for analysis of individual columns.
Supplemental Data
Four Supplemental Figures can be found with this article online at
http://www.immunity.com/cgi/content/full/26/1/117/DC1/.
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